Nonsteroidal anti-inflammatory drugs (NSAID) have been highly effective in preventing
colon, urinary bladder, and skin cancer preclinically, and also in clinical trials of colon …

Urinary bladder cancer prevention studies were performed with the nonsteroidal anti-
inflammatory drugs (NSAID) naproxen (a standard NSAID with a good cardiovascular …

Colorectal cancer is the second leading cause of cancer death in the USA Recent research
suggests that nonsteroidal anti-inflammatory drugs (NSAIDs) are effective in the prevention …

Nitric oxide–releasing nonsteroidal anti-inflammatory drugs (NO-NSAID) are promising
chemoprevention agents; unlike conventional NSAIDs, they seem free of appreciable …

Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NO-NSAIDs), consisting of a
known nonsteroidal anti-inflammatory drug (NSAID) and a nitric oxide (NO)-releasing group …

A seminal advance in the prevention of colon cancer has been the observation that
nonsteroidal antiinflammatory drugs (NSAIDs) reduce the incidence of and mortality from …

The treatment of colorectal cancer continues to improve, but it still remains the second
leading cause of cancer-related death in the United States. In 2001, there will be over …

Regular use of nonsteroidal anti-inflammatory drugs is associated with a significantly lower
incidence of several types of cancer, particularly those affecting the gastrointestinal tract …

Use of non‐steroidal anti‐inflammatory drugs (NSAIDs) for chemoprevention of colon cancer
has been hindered by their potential gastro‐intestinal toxicity. Nabumetone, which is …

Although nonsteroidal anti-inflammatory drugs (NSAID), including sulindac, have been used
extensively as chemopreventive agents for colorectal cancer, results are not consistent …